NCT00177281View on ClinicalTrials.gov

Safety Study of S-CKD602 in Patients With Advanced Malignancies

PHASE1CompletedINTERVENTIONAL

Enrollment

45

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions

Cancer

Interventions

DRUG

S CKD602

Trial Locations (1)

15232

University of Pittsburgh Medical Center, Pittsburgh

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

ALZA

INDUSTRY

lead

University of Pittsburgh

OTHER

NCT00177281 - Safety Study of S-CKD602 in Patients With Advanced Malignancies | Biotech Hunter | Biotech Hunter